(ARMR) |
| 0 (0%) 09-16 01:58 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | |
| 52w Low: |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 03 Sep 2026
A fentanyl vaccine produced an immune response in humans. ARMR is testing doses. - Stock Titan
Thu, 03 Sep 2026
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company - Yahoo Finance
Tue, 23 Jun 2026
SRX Global makes strategic early-stage investment in ARMR Sciences - Dealroom
Tue, 23 Jun 2026
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences - GlobeNewswire
Tue, 23 Jun 2026
SRX Global Invests in ARMR Sciences to Advance Fentanyl Countermeasure Development - citybiz
Mon, 15 Jun 2026
New motorbike security range with a wallet friendly price now at Sportsbikeshop - Motorcycle News
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
